HOOKIPA Pharma Inc. is a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform.

$1.47  +0.01 (0.69%)
As of 09/23/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/18/2019
Outstanding shares:  51,654,530
Average volume:  180,631
Market cap:   $75,932,159
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJ5K4M7
Valuation   (See tab for details)
PE ratio:   -0.99
PB ratio:   0.54
PS ratio:   14.22
Return on equity:   -51.64%
Net income %:   -1,430.62%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy